Intrinsic Value

BiondVax Pharmaceuticals Ltd. (BVXV)


-0.09 (-5.10%)

Enterprise Value -
Net Debt 15.70
Equity Value -
Shares Outstanding 10.75
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt